Trials / Unknown
UnknownNCT03735511
A Real World Study of Apatinib in Treatment of Patients With Gastric Carcinoma
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 270 (actual)
- Sponsor
- Henan Cancer Hospital · Other Government
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The study was designed to evaluate the efficacy and safety of apatinib in the treatment of patients with gastric carcinoma.
Detailed description
The study is a real-world non-interventional retrospective study and will collect the original medical records of patients with gastric carcinoma treated with apatinib from 2015 to 2018 in Henan Cancer Hospital. Clinical data such as patient demographic, history of treatments, tumor biological characteristics and adverse events will be analyzed to evaluate the efficacy and safety of apatinib and explore the risk factors of prognosis in patients with gastric carcinoma.
Conditions
Timeline
- Start date
- 2018-11-20
- Primary completion
- 2020-08-01
- Completion
- 2020-08-01
- First posted
- 2018-11-08
- Last updated
- 2020-04-27
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03735511. Inclusion in this directory is not an endorsement.